Precision oncology advancements have led to new treatment options for gastric cancer, including immunotherapy and targeted ...

Quantum Biopharma expects data from two now-completed, FDA-requested toxicology studies to support clinical testing of its ...

The drug is not considered a cure, but results from clinical trials point to major advancement for a devastating cancer ...

Despite the definitive failure of Novo Nordisk’s semaglutide in Alzheimer’s, biotech executives, analysts and other industry ...

Alzheimer’s disease blood test developer Quanterix put forward new clinical data from its Simoa assay, which it described as ...

A new proposal in JAMA Internal Medicine suggests that the FDA should create an approval pathway for medical AI tools that parallels how physicians are trained and licensed.

From respiratory infection to fatal neurological disease, EHV-1 demands rapid PCR diagnosis, and detection protocols impact ...

For leaders preparing for 2026, a critical step is to map where processes should remain human or become automated. Audit your ...

From robotic surgery performed 7,000 miles away to the first blood test to help diagnose Alzheimer’s disease, 2025 has been a ...

A few 2025 trials pointed in the same direction: toward treatments built to modify disease biology and better ways to measure ...

All of this disproportionately affects the elderly. In a 2023 study of patients with a median age of 75, approximately 30% of ...

Groundbreaking research at Seattle Children's Hospital provides critical genetic diagnoses for newborns within 48 hours.